Close this search box.

Merck Monopoly & Price Gouging

From our September 20, 2018 Facebook Post:

Myth: Pharmaceutical companies don’t make any money on vaccines.

“Merck & Co. Inc. faces a class action by pediatricians alleging the pharma company used its monopoly…to unlawfully drive up prices on the rotavirus vaccine…

Any clinic that wanted to buy rotavirus vaccine from GSK had to be willing to accept substantial penalties when purchasing all other Merck vaccines, ‘including those for which there is no other supplier,’ the complaint said.

The move kept GSK from competing on price with its new product, Sugartown said. Instead of prices going down, as one would expect when a competing product enters the market, ‘Merck has maintained and increased the price,’ the complaint said.”


Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top